🟢 Structure Therapeutics is trading 4.4% up in pre-market as major indices rise ahead of inflation report

Structure Therapeutics is trading 4.4% up at $41.30, with the pre-market rebound appearing aligned with firmer broader-market sentiment ahead of the scheduled inflation report.

• It fell 4.07% to $39.55 on September 10.
• No new company-specific announcement was identified for September 11; the latest official release remains the September 8 clinical-data update.
• Recent clinical data and analyst support remain background factors, not a confirmed immediate catalyst.